Bioelectronics Corp (BIEL)

[Gailm]

February 24, 2014 the last "skyrocket" threat

OH WAIT IT THE SAME NEWS-- that everyone is waiting for NOW!

Snapshot of the Company back then:

Cash and cash equivalents - $35 thousand
Total current assets - $869 thousand
Total current liabilities - $3.3 Million
Sales - $110 thousand
Gross profit from sales - $5 thousand
Net loss - $734 thousand

Potential investors would do well to remember that the reclassification of BIEL's product is not yet a fact. As it is, the company certainly needs the clearance for the American market, because its Canadian and European sales don't seem to be able to sustain it, as its latest financial report clearly shows.

3 years later............any day now......any day now.